Skip to main content
Log in

Antibodies to brain tissue in sera of schizophrenic patients

Preliminary findings

  • Original Articles
  • Published:
European Archives of Psychiatry and Clinical Neuroscience Aims and scope Submit manuscript

Summary

The sera of 30 patients suffering from schizophrenia (DSM III) and 30 neurological controls were tested for antibrain antibodies in a blind indirect immunofluorescence assay. We found IgG- and IgM-binding in the sera of 22 patients, but only 4 out of the 30 age- and sex-matched controls. The binding was mainly directed to neurons from the frontal cortex and septal area, areas, which are regarded as important in the development of schizophrenic illness. These preliminary data are presented, to encourage other immunological studies in schizophrenia research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aarli JA, Aparicio SR, Lumsden CE, Tönder O (1975) Binding of normal human IgG to myelin sheaths, glia and neurons. Immunology 28:171–185

    Google Scholar 

  2. Ahokas A, Koskiniemi M-L, Vaheri A, Rimón R (1985) Altered white cell count, protein concentration and oligoclonal IgG bands in the csf of many patients with acute psychiatric disorders. Neuropsychobiology 14:1–4

    Google Scholar 

  3. Axelsson R, Martensson E, Alling C (1982) Impairment, of the blood-brain barrier as an aetiological factor in paranoid psychosis. Br J Psychiatry 141:273–281

    Google Scholar 

  4. Baron M, Stern M, Anavi R, Witz IP (1977) Tissue-binding factor in schizophrenic sera: a clinical and genetic study. Biol Psychiatry 12:199–219

    Google Scholar 

  5. Bergen JR, Grinspoon L, Pyle HM, Martinez JL, Pennell RB (1980) Immunologic studies in schizophrenic and control subjects. Biol Psychiatry 15:369–379

    Google Scholar 

  6. Bock E, Weeke B, Rafaelsen OJ (1971) Serum proteins in acutely psychotic patients. J Psychiatr Res 9:1–9

    Google Scholar 

  7. Boehme DH, Cottrell JC, Dohan FC, Hillegass LM (1974) Demonstration of nuclear and cytoplasmic fluorescence in brain tissues of schizophrenic and nonschizophrenic patients. Biol Psychiatry 8:89–94

    Google Scholar 

  8. Bogerts B, Meertz E, Schönfeldt-Bausch R (1985) Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiatry 42:784–791

    Google Scholar 

  9. Burch PRJ (1964) Schizophrenia: some new aetiological considerations. Br J Psychiatry 110:818–824

    Google Scholar 

  10. DeLisi LE, Crow TJ (1986) Is schizophrenia a viral or immunologic disorder? Psychiatr Clin North Am 9:115–132

    Google Scholar 

  11. DeLisi LE, Weinberger DR, Potkin S, Neckers LM, Shiling DJ, Wyatt RJ (1981) Quantitative determination of immunoglobulins in CSF and plasma of chronic schizophrenic patients. Br J Psychiatry 139:513–518

    Google Scholar 

  12. DeLisi LE, Weber RJ, Pert CB (1985) Are there antibodies against brain in sera from schizophrenic patients? Review and prospectus. Biol Psychiatry 20:110–115

    Google Scholar 

  13. Ehrnst A, Wiesel F-A, Bjerkenstedt L, Tribukait B, Jonsson J (1982) Failure to detect immunologic stigmata in schizophrenia. Neuropsychobiology 8:169–171

    Google Scholar 

  14. Falkai P, Bogerts B, Rozumek M (1988) Limbic pathology in schizophrenia: the entorhinal region — a morphometric study. Biol Psychiatry 24:515–521

    Google Scholar 

  15. Fudenberg HH, Whitten HD, Chou YK, Arnaud P, Shums AA, Khansari NK (1984) Sigma receptors and autoimmune mechanisms in schizophrenia: preliminary findings and hypotheses. Biomed Pharmacother 38:285–290

    Google Scholar 

  16. Heath RG, Krupp IM (1967) Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques. Arch Gent Psychiatry 16:1–9

    Google Scholar 

  17. Heath RG, McCarron KL, O'Neil CE (1989) Antiseptal brain antibody in IgG of schizophrenic patients. Biol Psychiatry 25:725–733

    Google Scholar 

  18. Henneberg A, Riedl B, Dumke HO, Kornhuber HH (1990) T-lymphocyte subpopulations in schizophrenic patients. Eur Arch Psychiatr Neurol Sci 239:283–284

    Google Scholar 

  19. Jakob H, Beckmann H (1989) Gross and histological criteria for developmental disorders in brains of schizophrenics. J R Soc Med 82:466–469

    Google Scholar 

  20. Kagami M, Koike T, Maruyama N, Takabayashi K, Tomioka H, Yoshida S, Kon Y (1987) Cytotoxic anti-lymphocyte antibody in schizophrenics. J Neurol 234:359–360

    Google Scholar 

  21. Kaiya H, Kematsu M, Ofuji M, Nishida A, Morikiyo M, Adachi S (1989) Computerised tomography in schizopheria. Familial versus non-famkilial forms of illness. Br J Psychiatry 155:444–450

    Google Scholar 

  22. Kelly RH, Ganguli R, Rabin BS (1987) Antibody to discrete areas of the brain in normal individuals and patients with schizophrenia. Biol Psychiatry 22:1488–1491

    Google Scholar 

  23. Knight JG, Knight A, Pert CB (1987) Is schizophrenia a virally triggered antireceptor autoimmune disease? In: Helmchen H, Henn FA (eds) Biological Perspectives of Schizophrenia. John Wiley & Sons, pp 107–127

  24. Knight JG, Knight A, Menkes DB, Mullen PE (1990) Autoantibodies against brain septal region antigens specific to unmedicated schizophrenia. Biol Psychiatry 28:467–474

    Google Scholar 

  25. Koliaskina G, Tsutsulkovskaya M, Domashneva I, Maznina T, Kielholz P, Gastpar M, Bunney W, Rafaelsen O, Heltberg J, Coppen A, Hippius H, Hoecherl B, Vartanian F (1980) Antithymic immune factor in schizophrenia. A world health organization study. Neuropsychobiology 6:349–355

    Google Scholar 

  26. Kornhuber HH, Kornhuber J (1987) A neuroimmunological challenge: schizophrenia as an autoimmune disease. Arch Ital Biol 125:271–272

    Google Scholar 

  27. Kornhuber J, Bauer K (1986) Störung der Blut-Liquor-Schranke bei Schizophrenie. Dtsch Med Wschr 26:1041

    Google Scholar 

  28. Lefvert AK, Pirskanen R, Eng H Sundevall A-C, Svanborg E (1989) B cell and autoantibody repertoire in a pair of monozygotic twins discordant for myasthenia gravis. Clin Immunol Immunopathol 53:161–170

    Google Scholar 

  29. Legros S, Mendlewicz J, Wybran J (1985) Immunoglobulins, autoantibodies and other serum protein, fractions in psychiatric disorders. Eur Arch Psychiatr Neurol Sci 235:9–11

    Google Scholar 

  30. Lehmann-Facius H (1937) Über die Liquordiagnose der Schizophrenien. Klin. Wochenschr 16:1646–1648

    Google Scholar 

  31. Leonardi A, Cocito L, Tabaton M, Bartolini A, Roccatagliata G (1982) CSF and serum IgG and albumin in schizophrenia. IRCS Medical Science Immunlogy and Allergy 10:812–813

    Google Scholar 

  32. Logan DG, Deodhar SD (1970) Schizophrenia, an immunologic disorder? JAMA 212, 10:1703–1704

    Google Scholar 

  33. Martin-du Pan R, Dayer JM (1982) Actions des neurotransmetteurs et des medicaments psychotropes sur le systeme immunitaire. Schweiz Med Wschr 112:1910–1920

    Google Scholar 

  34. Müller N, Hofschuster E, Ackenheil M (1989) Quantifizierung zellulärer Immunfunktionen als State- bzw. Trait-Marker. In: Saletu B (ed) Biologische Psychiatrie. 2. Drei-Länder-Symposium Innsbruck, September 1988. Thieme Verlag, Stuttgart, New York, pp 113–118

    Google Scholar 

  35. Pandey RS, Gupta AK, Chaturvedi UC (1981) Autoimmune model of schizophrenia with special reference to antibrain antibodies. Biol Psychiatry 16,12:1123–1136

    Google Scholar 

  36. Pulkkinen E (1977) Immunoglobulins, psychopathology and prognosis in schizophrenia. Acta Psychiatr Scand 56:173–182

    Google Scholar 

  37. Roos RP, Davis K, Meltzer HY (1985) Immunoglobulin studies in patients with psychiatric diseases. Arch Gen Psychiatry 42:124–128

    Google Scholar 

  38. Rubin RT (1965) Investigation of precipitins to human brain in sera of psychotic patients. Br J Psychiatry 111:1003–1006

    Google Scholar 

  39. Saunders JC, Muchmore E (1964) Phenothiazine effect on human antibody synthesis. Br J Psychiatry 110:84–89

    Google Scholar 

  40. Solomon GF, Allansmith M, McClelan B, Amkraut A (1969) Immunoglobulins in psychiatric patients. Arch Gen Psychiatry 20:272–277

    Google Scholar 

  41. Strahilevitz M, Davis SD (1970) Increased IgA in schizophrenic patients. Lancet II:370

    Google Scholar 

  42. Takada A, Takada Y, Ito U, Minowada J (1974) Shared antigenic determinants betwen human brain and human T-cell line. Clin Exp Immunol 18:491–498

    Google Scholar 

  43. Thompson RA (1988) Laboratory investigations in clinical immunology: methods, pitfalls and clinical indications Clin Exp Immunol 74:494–503

    Google Scholar 

  44. Vartanian ME, Kolyaskina GI, Lozovsky DV, Burbaeva GS, Ignatov SA (1978) Aspects of humoral and cellular immunity in schizophrenia. In: Bergsma, Daniel (eds) Neurochemical and immunologic components in schizophrenia. Birth Defects XIV,5. Liss New York, pp 339–364

    Google Scholar 

  45. Von Brauchitsch H (1972) Antinuclear factor in psychiatric disorder. Am J Psychiatry 128:1552–1554

    Google Scholar 

  46. Watanabe M, Funahashi T, Suzuki T, Nomura, S, Nakazawa T, Noguchi T, Tsukada Y (1982) Antithymic antibodies in schizophrenic sera. Biol Psychiatry 17:699–710

    Google Scholar 

  47. Whittingham S, Mackay IR, Jones IH, Davies B (1968) Absence of brain antibodies in patients with schizophrenia. BMJ 1:347–348

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henneberg, A.E., Ruffert, S., Henneberg, HJ. et al. Antibodies to brain tissue in sera of schizophrenic patients. Eur Arch Psychiatry Clin Nuerosci 242, 314–317 (1993). https://doi.org/10.1007/BF02190392

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02190392

Key words

Navigation